Robert Dean
Family Medicine · Greenwell Springs, LANPI 1659418325
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 22.3%. Reporting peaked in 2021 at $2,210 and has fallen 96.7% since, to $73 in 2025.
Across 236 payments — averaging $25.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Janssen Scientific Affairs, LLC$1K
- Novo Nordisk$684
- Sanofi-aventis U.S. LLC$396
- Takeda Pharmaceuticals U.S.A., Inc.$312
- Pfizer$295
- plus $2K from 24 others
What the payments were for
- Consulting fees$2,50041%
- Speaking & faculty fees$601%
- Food & beverage$3,54958%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $1,363 |
| Janssen Scientific Affairs, LLC | 1 | $1,250 |
| Novo Nordisk | 48 | $684 |
| Sanofi-aventis U.S. LLC | 28 | $396 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $312 |
| Pfizer | 25 | $295 |
| Abbott | 13 | $282 |
| Boehringer Ingelheim | 13 | $214 |
| Merck | 13 | $171 |
| Antares Pharma, Inc. | 8 | $163 |
| Lilly USA, LLC | 12 | $158 |
| AbbVie(2 entities) | 7 | $120 |
| Eisai Inc. | 5 | $98 |
| AstraZeneca | 5 | $70 |
| Amarin Pharma, Inc. | 5 | $67 |
| Sanofi | 1 | $60 |
| Amgen(2 entities) | 4 | $49 |
| GSK | 3 | $48 |
| Genentech USA, Inc. | 3 | $43 |
| Adlon Therapeutics L.p. | 3 | $42 |
| Neos Therapeutics, LP | 3 | $41 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Acerus Pharmaceuticals Corporation | 2 | $25 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| Shire North American Group Inc | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$2,500
How this compares
$6,109 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Greenwell Springs
- Christine SmithBaton Rouge$185K
- Thomas DansbyMonroe$169K
- Michael FlemingShreveport$165K
- Robert St AmantGonzales$156K
- William HathawaySpringhill$105K
- Cesar GonzalesWest Monroe$94K
- Phillip ConnerSulphur$71K
- Richard JeansonneMandeville$49K
- Leonard TreanorHammond$29K
- Shannon HaasMandeville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.